Overriding of cyclin-dependent kinase inhibitors by high and low risk human papillomavirus types: evidence for an in vivo role in cervical lesions.

Zehbe, I

Overriding of cyclin-dependent kinase inhibitors by high and low risk human papillomavirus types: evidence for an in vivo role in cervical lesions. [electronic resource] - Oncogene Apr 1999 - 2201-11 p. digital

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

0950-9232

10.1038/sj.onc.1202549 doi


Carcinoma, Squamous Cell--chemistry
Cell Compartmentation
Cell Cycle
Cell Cycle Proteins
Cell Division
Cell Transformation, Viral
Cervix Uteri--cytology
Condylomata Acuminata--metabolism
Cyclin A--analysis
Cyclin-Dependent Kinase Inhibitor p21
Cyclin-Dependent Kinase Inhibitor p27
Cyclin-Dependent Kinases--antagonists & inhibitors
Cyclins--analysis
Female
Humans
Microtubule-Associated Proteins--analysis
Neoplasm Invasiveness
Papillomaviridae--classification
Papillomavirus Infections--metabolism
Precancerous Conditions--metabolism
Tumor Suppressor Proteins
Tumor Virus Infections--metabolism
Uterine Cervical Diseases--metabolism
Uterine Cervical Neoplasms--chemistry
Viral Proteins--physiology
Virus Replication
Uterine Cervical Dysplasia--enzymology